FDA introduces new MedWatch reporting and learning tools
As it celebrates the 20th anniversary of its MedWatch program, FDA has launched two new tools designed to make it easier for consumers and healthcare professionals to report product information to the agency
As it celebrates the 20th anniversary of its MedWatch program, FDA has launched two new tools designed to make it easier for consumers and healthcare professionals to report product information to the agency.
MedWatch allows healthcare professionals and consumers to submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product.
The agency uses that information to make necessary changes to medication labels, to issue product recalls, warning, and safety messages, and to determine how patients receiving products should be monitored.
FDA has introduced a new form that’s more consumer-friendly. It was developed with input from groups such as AARP, Consumers Union, and the National Women's Health Network.
The agency has also introduced a new web-based learning tool, MedWatchLearn, which instructs students, healthcare professionals and consumers on how to correctly complete a report. It also provides examples of properly prepared reports.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
